Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Poliovirus Vaccines (approved 1990)
Apnea (Phase 4)
Communicable Diseases (Phase 2)
Diphtheria (Phase 4)
Haemophilus influenzae (Phase 3)
Haemophilus influenzae type b (Phase 4)
Healthy Volunteers (Phase 4)
Hepatitis B (Phase 4)
Hospitalization (Phase 4)
Immunization (Phase 4)
Immunization, Secondary (Phase 1/Phase 2)
Infant, Premature, Diseases (Phase 4)
Influenza, Human (Phase 4)
Meningitis (Phase 3)
Meningitis, Bacterial (Phase 3)
Meningitis, Meningococcal (Phase 3)
Meningococcal Infections (Phase 3)
Mortality (Phase 4)
Neisseria meningitidis (Phase 4)
Papillomavirus Infections (Phase 3)
Pertussis Vaccine (Phase 4)
Pneumonia, Staphylococcal (Phase 3)
Poliomyelitis (Phase 4)
Poliovirus Vaccines (Phase 2)
Rotavirus Infections (Phase 4)
SARS-CoV-2 (Phase 4)
Streptococcal Infections (Phase 4)
Tetanus (Phase 4)
Tropical Medicine (Phase 3)
Vaccination (Phase 4)
Vaccines (Phase 4)
Whooping Cough (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
